Investigators accessed longitudinal human data from ebola virus vaccination for signals of efficacy against the Bundibugyo species now surging in the Democratic Republic of Congo.
|Articles|June 19, 2023
FDA Alerts Public of Expanding Strawberry Recall Over Concerns of Hepatitis A Exposure
Author(s)John Parkinson
The agency said that in recent days a few more suppliers initiated a voluntary recall of additional select packages sold at national stores.
Advertisement
Last Tuesday, the FDA announced that additional suppliers who provide strawberries to consumer stores such as Walmart and Costco have strawberries that were part of a voluntary recall. This has been an ongoing
According to the FDA, on June 12, the Willamette Valley Fruit Co. of Salem, Oregon, initiated a voluntary recall of select packages of frozen fruit products containing strawberries. Recalled products include Great Value Mixed Fruit 4-lb, Great Value Sliced Strawberries 4-lb, Great Value Antioxidant Fruit Blend 2-lb, Rader Farms Organic Fresh Start Smoothie Blend 48-oz. bag (each bag consists of six 8-oz packages), and Rader Farms Organic Berry Trio 3-lb.
The strawberries were sold to consumer stores Costco, Walmart, and HEB.
On June 7, 2023, Wawona Frozen Foods said it voluntarily recalled year-old packages of its Organic DayBreak Blend distributed to Costco Wholesale stores in Arizona, California, Colorado, Utah and Washington from April 15, 2022 to June 26, 2022.
In addition, California Splendor, Inc. of San Diego, California, has voluntarily recalled certain lots of 4-lb. bags of Kirkland Signature Frozen Organic Whole Strawberries that were sold at Costco stores in Los Angeles and Hawaii, and at two San Diego business centers. And Scenic Fruit Company of Gresham, Oregon, has performed a voluntarily recalled frozen organic strawberries, sold to Costco, Aldi, KeHE, Vital Choice Seafood, and PCC Community Markets in certain states and to Trader Joe’s nationwide.
The FDA also reported the latest update on the food-borne outbreak. As of June 14, there has been 9 total cases with 6 in Washington state, 2 in California, and 1 in Oregon. There has been 3 hospitalizations and no deaths. The last reported illness was April 12.
To find more information on this recall and the specific products involved in it and the states where the products were distributed, interested parties can go to this
Advertisement
Related to this article
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.